Rockwell Medical Inc (RMTI.OQ)
RMTI.OQ on NASDAQ Stock Exchange Global Market
3.87USD
21 May 2013
3.87USD
21 May 2013
Price Change (% chg)
$0.35 (+9.94%)
$0.35 (+9.94%)
Prev Close
$3.47
$3.47
Open
$3.60
$3.60
Day's High
$3.90
$3.90
Day's Low
$3.57
$3.57
Volume
265,224
265,224
Avg. Vol
114,801
114,801
52-wk High
$10.70
$10.70
52-wk Low
$3.16
$3.16
About
Rockwell Medical, Inc., formerly Rockwell Medical Technologies, Inc., manufactures hemodialysis concentrate solutions and dialysis kits, and it sells, distributes and delivers these and other ancillary hemodialysis products primarily to hemodialysis providers in the United States, as well as internationally primarily in Asia,... (more)
Overall
| Beta: | 0.80 |
| Market Cap (Mil.): | $151.92 |
| Shares Outstanding (Mil.): | 39.26 |
| Dividend: | -- |
| Yield (%): | -- |
Financials
| RMTI.OQ | Industry | Sector | |
|---|---|---|---|
| P/E (TTM): | -- | 54.65 | 35.13 |
| EPS (TTM): | -2.82 | -- | -- |
| ROI: | -780.23 | 0.83 | 18.83 |
| ROE: | -780.31 | 1.79 | 19.68 |
Rockwell Medical reports positive data on iron deficiency drug
- Rockwell Medical Inc reported positive results from a clinical study of its iron deficiency treatment for patients on hemodialysis.
UPDATE 1-Rockwell Medical reports positive data on iron deficiency drug
Feb 4 - Rockwell Medical Inc reported positive results from a clinical study of its iron deficiency treatment for patients on hemodialysis.
BRIEF-Rockwell Medical jumps 24 percent in premarket
NEW YORK, Feb 4 - Rockwell Medical Inc : * Shares jump 24 percent in premarket trading after drug trial results
Competitors
| Price | Change | |
|---|---|---|
| DAIICHI SANKYO COMPANY, LIMITED (4568.T) | ¥1,938 | -9.00 |
| Abbott Laboratories (ABT.N) | $37.72 | -0.09 |
| Sanofi SA (SASY.PA) | €84.92 | -0.22 |
| Fresenius Medical Care AG & Co. KGaA (FMEG.DE) | €53.30 | +0.12 |
| Actavis Inc (ACT.N) | $130.20 | +3.05 |
| Galenica AG (GALN.S) | CHF631.00 | -0.50 |
| Cantel Medical Corp. (CMN.N) | $34.65 | +0.21 |
Earnings vs.
Estimates
Analyst Research Reports
| Report Title | Price |
|---|---|
|
Provider: Thomson Reuters Stock Report
|
$25.00
|
|
Provider: Pechala's Reports
|
$15.00
|
|
Provider: Reuters Investment Profile
|
$20.00
|
|
Provider: S&P Capital IQ Quantitative Report
|
$69.00
|
|
Provider: ValuEngine, Inc.
|
$127.00
|
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

